世界の経口抗糖尿病薬市場:販売動向2017

QYResearchが発行した調査報告書(QYR70324380)
◆英語タイトル:Global Oral Antidiabetic Drugs Sales Market Report 2017
◆商品コード:QYR70324380
◆発行会社(リサーチ会社):QYResearch
◆発行日:2017年1月20日
◆ページ数:126
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、経口抗糖尿病薬の世界市場について調査・分析し、経口抗糖尿病薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、経口抗糖尿病薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・経口抗糖尿病薬市場概要
・経口抗糖尿病薬のメーカー別販売量・メーカー別シェア
・経口抗糖尿病薬の世界市場:種類別販売量・市場シェア
・経口抗糖尿病薬の世界市場:用途別販売量・市場シェア
・経口抗糖尿病薬の世界市場:地域別販売量・市場シェア
・経口抗糖尿病薬のアメリカ市場規模
・経口抗糖尿病薬の中国市場規模
・経口抗糖尿病薬のヨーロッパ市場規模
・経口抗糖尿病薬の日本市場規模
・経口抗糖尿病薬の東南アジア市場規模
・経口抗糖尿病薬のインド市場規模
・経口抗糖尿病薬のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・経口抗糖尿病薬のコスト分析・価格動向
・経口抗糖尿病薬の産業チェーン(サプライチェーン分析)
・経口抗糖尿病薬のマーケティング戦略・販売チャネル、流通業者
・経口抗糖尿病薬市場への影響要因分析
・経口抗糖尿病薬の世界市場予測
・経口抗糖尿病薬のアメリカ市場予測
・経口抗糖尿病薬の中国市場予測
・経口抗糖尿病薬のヨーロッパ市場予測
・経口抗糖尿病薬の日本市場予測
・経口抗糖尿病薬の東南アジア市場予測
・経口抗糖尿病薬のインド市場予測
・経口抗糖尿病薬の種類別世界市場予測
・経口抗糖尿病薬の用途別世界市場予測
...
【レポートの概要】

Notes:Sales, means the sales volume of Oral Antidiabetic Drugs
Revenue, means the sales value of Oral Antidiabetic Drugs

This report studies sales (consumption) of Oral Antidiabetic Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Eli Lilly
Abbott
Biocon
Sanofi
Sunpharma
Novartis
Novo Nordisk
Merck
Pfizer

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Oral Antidiabetic Drugs in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Sulfonylureas
Meglitinides
Biguanides
Alpha-glucosidase Inhibitors
Split by applications, this report focuses on sales, market share and growth rate of Oral Antidiabetic Drugs in each application, can be divided into
Hospital
Clinic
Individual
Others

【レポートの目次】

Table of Contents

Global Oral Antidiabetic Drugs Sales Market Report 2017
1 Oral Antidiabetic Drugs Overview
1.1 Product Overview and Scope of Oral Antidiabetic Drugs
1.2 Classification of Oral Antidiabetic Drugs
1.2.1 Sulfonylureas
1.2.2 Meglitinides
1.2.3 Biguanides
1.2.4 Alpha-glucosidase Inhibitors
1.3 Application of Oral Antidiabetic Drugs
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Individual
1.3.4 Others
1.4 Oral Antidiabetic Drugs Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Oral Antidiabetic Drugs (2012-2022)
1.5.1 Global Oral Antidiabetic Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2022)

2 Global Oral Antidiabetic Drugs Competition by Manufacturers, Type and Application
2.1 Global Oral Antidiabetic Drugs Market Competition by Manufacturers
2.1.1 Global Oral Antidiabetic Drugs Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Oral Antidiabetic Drugs Revenue and Share by Manufacturers (2012-2017)
2.2 Global Oral Antidiabetic Drugs (Volume and Value) by Type
2.2.1 Global Oral Antidiabetic Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Oral Antidiabetic Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Oral Antidiabetic Drugs (Volume and Value) by Regions
2.3.1 Global Oral Antidiabetic Drugs Sales and Market Share by Regions (2012-2017)
2.3.2 Global Oral Antidiabetic Drugs Revenue and Market Share by Regions (2012-2017)
2.4 Global Oral Antidiabetic Drugs (Volume) by Application

3 United States Oral Antidiabetic Drugs (Volume, Value and Sales Price)
3.1 United States Oral Antidiabetic Drugs Sales and Value (2012-2017)
3.1.1 United States Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
3.2 United States Oral Antidiabetic Drugs Sales and Market Share by Manufacturers
3.3 United States Oral Antidiabetic Drugs Sales and Market Share by Type
3.4 United States Oral Antidiabetic Drugs Sales and Market Share by Application

4 China Oral Antidiabetic Drugs (Volume, Value and Sales Price)
4.1 China Oral Antidiabetic Drugs Sales and Value (2012-2017)
4.1.1 China Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
4.2 China Oral Antidiabetic Drugs Sales and Market Share by Manufacturers
4.3 China Oral Antidiabetic Drugs Sales and Market Share by Type
4.4 China Oral Antidiabetic Drugs Sales and Market Share by Application

5 Europe Oral Antidiabetic Drugs (Volume, Value and Sales Price)
5.1 Europe Oral Antidiabetic Drugs Sales and Value (2012-2017)
5.1.1 Europe Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
5.2 Europe Oral Antidiabetic Drugs Sales and Market Share by Manufacturers
5.3 Europe Oral Antidiabetic Drugs Sales and Market Share by Type
5.4 Europe Oral Antidiabetic Drugs Sales and Market Share by Application

6 Japan Oral Antidiabetic Drugs (Volume, Value and Sales Price)
6.1 Japan Oral Antidiabetic Drugs Sales and Value (2012-2017)
6.1.1 Japan Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
6.2 Japan Oral Antidiabetic Drugs Sales and Market Share by Manufacturers
6.3 Japan Oral Antidiabetic Drugs Sales and Market Share by Type
6.4 Japan Oral Antidiabetic Drugs Sales and Market Share by Application
7 Southeast Asia Oral Antidiabetic Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Oral Antidiabetic Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Oral Antidiabetic Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Oral Antidiabetic Drugs Sales and Market Share by Type
7.4 Southeast Asia Oral Antidiabetic Drugs Sales and Market Share by Application
8 India Oral Antidiabetic Drugs (Volume, Value and Sales Price)
8.1 India Oral Antidiabetic Drugs Sales and Value (2012-2017)
8.1.1 India Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
8.2 India Oral Antidiabetic Drugs Sales and Market Share by Manufacturers
8.3 India Oral Antidiabetic Drugs Sales and Market Share by Type
8.4 India Oral Antidiabetic Drugs Sales and Market Share by Application

9 Global Oral Antidiabetic Drugs Manufacturers Analysis
9.1 Eli Lilly
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Oral Antidiabetic Drugs Product Type, Application and Specification
9.1.2.1 Sulfonylureas
9.1.2.2 Meglitinides
9.1.3 Eli Lilly Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Abbott
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Oral Antidiabetic Drugs Product Type, Application and Specification
9.2.2.1 Sulfonylureas
9.2.2.2 Meglitinides
9.2.3 Abbott Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Biocon
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Oral Antidiabetic Drugs Product Type, Application and Specification
9.3.2.1 Sulfonylureas
9.3.2.2 Meglitinides
9.3.3 Biocon Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Sanofi
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Oral Antidiabetic Drugs Product Type, Application and Specification
9.4.2.1 Sulfonylureas
9.4.2.2 Meglitinides
9.4.3 Sanofi Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Sunpharma
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Oral Antidiabetic Drugs Product Type, Application and Specification
9.5.2.1 Sulfonylureas
9.5.2.2 Meglitinides
9.5.3 Sunpharma Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Novartis
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Oral Antidiabetic Drugs Product Type, Application and Specification
9.6.2.1 Sulfonylureas
9.6.2.2 Meglitinides
9.6.3 Novartis Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Novo Nordisk
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Oral Antidiabetic Drugs Product Type, Application and Specification
9.7.2.1 Sulfonylureas
9.7.2.2 Meglitinides
9.7.3 Novo Nordisk Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Merck
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Oral Antidiabetic Drugs Product Type, Application and Specification
9.8.2.1 Sulfonylureas
9.8.2.2 Meglitinides
9.8.3 Merck Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Pfizer
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Oral Antidiabetic Drugs Product Type, Application and Specification
9.9.2.1 Sulfonylureas
9.9.2.2 Meglitinides
9.9.3 Pfizer Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview

10 Oral Antidiabetic Drugs Maufacturing Cost Analysis
10.1 Oral Antidiabetic Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Oral Antidiabetic Drugs
10.3 Manufacturing Process Analysis of Oral Antidiabetic Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Oral Antidiabetic Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Oral Antidiabetic Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Oral Antidiabetic Drugs Market Forecast (2017-2022)
14.1 Global Oral Antidiabetic Drugs Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Oral Antidiabetic Drugs Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Oral Antidiabetic Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Oral Antidiabetic Drugs Price and Trend Forecast (2017-2022)
14.2 Global Oral Antidiabetic Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Oral Antidiabetic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Oral Antidiabetic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Oral Antidiabetic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Oral Antidiabetic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Oral Antidiabetic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Oral Antidiabetic Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Oral Antidiabetic Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Oral Antidiabetic Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Oral Antidiabetic Drugs
Table Classification of Oral Antidiabetic Drugs
Figure Global Sales Market Share of Oral Antidiabetic Drugs by Type in 2015
Figure Sulfonylureas Picture
Figure Meglitinides Picture
Figure Biguanides Picture
Figure Alpha-glucosidase Inhibitors Picture
Table Applications of Oral Antidiabetic Drugs
Figure Global Sales Market Share of Oral Antidiabetic Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure Individual Examples
Figure Others Examples
Figure United States Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2022)
Figure China Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2022)
Figure India Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2022)
Figure Global Oral Antidiabetic Drugs Sales and Growth Rate (2012-2022)
Figure Global Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2022)
Table Global Oral Antidiabetic Drugs Sales of Key Manufacturers (2012-2017)
Table Global Oral Antidiabetic Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Oral Antidiabetic Drugs Sales Share by Manufacturers
Figure 2016 Oral Antidiabetic Drugs Sales Share by Manufacturers
Table Global Oral Antidiabetic Drugs Revenue by Manufacturers (2012-2017)
Table Global Oral Antidiabetic Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Oral Antidiabetic Drugs Revenue Share by Manufacturers
Table 2016 Global Oral Antidiabetic Drugs Revenue Share by Manufacturers
Table Global Oral Antidiabetic Drugs Sales and Market Share by Type (2012-2017)
Table Global Oral Antidiabetic Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Oral Antidiabetic Drugs by Type (2012-2017)
Figure Global Oral Antidiabetic Drugs Sales Growth Rate by Type (2012-2017)
Table Global Oral Antidiabetic Drugs Revenue and Market Share by Type (2012-2017)
Table Global Oral Antidiabetic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Antidiabetic Drugs by Type (2012-2017)
Figure Global Oral Antidiabetic Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Oral Antidiabetic Drugs Sales and Market Share by Regions (2012-2017)
Table Global Oral Antidiabetic Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Oral Antidiabetic Drugs by Regions (2012-2017)
Figure Global Oral Antidiabetic Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Oral Antidiabetic Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Oral Antidiabetic Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Oral Antidiabetic Drugs by Regions (2012-2017)
Figure Global Oral Antidiabetic Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Oral Antidiabetic Drugs Sales and Market Share by Application (2012-2017)
Table Global Oral Antidiabetic Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Oral Antidiabetic Drugs by Application (2012-2017)
Figure Global Oral Antidiabetic Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
Figure United States Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
Figure United States Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
Table United States Oral Antidiabetic Drugs Sales by Manufacturers (2012-2017)
Table United States Oral Antidiabetic Drugs Market Share by Manufacturers (2012-2017)
Table United States Oral Antidiabetic Drugs Sales by Type (2012-2017)
Table United States Oral Antidiabetic Drugs Market Share by Type (2012-2017)
Table United States Oral Antidiabetic Drugs Sales by Application (2012-2017)
Table United States Oral Antidiabetic Drugs Market Share by Application (2012-2017)
Figure China Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
Figure China Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
Figure China Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
Table China Oral Antidiabetic Drugs Sales by Manufacturers (2012-2017)
Table China Oral Antidiabetic Drugs Market Share by Manufacturers (2012-2017)
Table China Oral Antidiabetic Drugs Sales by Type (2012-2017)
Table China Oral Antidiabetic Drugs Market Share by Type (2012-2017)
Table China Oral Antidiabetic Drugs Sales by Application (2012-2017)
Table China Oral Antidiabetic Drugs Market Share by Application (2012-2017)
Figure Europe Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
Figure Europe Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
Table Europe Oral Antidiabetic Drugs Sales by Manufacturers (2012-2017)
Table Europe Oral Antidiabetic Drugs Market Share by Manufacturers (2012-2017)
Table Europe Oral Antidiabetic Drugs Sales by Type (2012-2017)
Table Europe Oral Antidiabetic Drugs Market Share by Type (2012-2017)
Table Europe Oral Antidiabetic Drugs Sales by Application (2012-2017)
Table Europe Oral Antidiabetic Drugs Market Share by Application (2012-2017)
Figure Japan Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
Figure Japan Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
Table Japan Oral Antidiabetic Drugs Sales by Manufacturers (2012-2017)
Table Japan Oral Antidiabetic Drugs Market Share by Manufacturers (2012-2017)
Table Japan Oral Antidiabetic Drugs Sales by Type (2012-2017)
Table Japan Oral Antidiabetic Drugs Market Share by Type (2012-2017)
Table Japan Oral Antidiabetic Drugs Sales by Application (2012-2017)
Table Japan Oral Antidiabetic Drugs Market Share by Application (2012-2017)
Figure Southeast Asia Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
Figure Southeast Asia Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
Table Southeast Asia Oral Antidiabetic Drugs Sales by Manufacturers (2012-2017)
Table Southeast Asia Oral Antidiabetic Drugs Market Share by Manufacturers (2012-2017)
Table Southeast Asia Oral Antidiabetic Drugs Sales by Type (2012-2017)
Table Southeast Asia Oral Antidiabetic Drugs Market Share by Type (2012-2017)
Table Southeast Asia Oral Antidiabetic Drugs Sales by Application (2012-2017)
Table Southeast Asia Oral Antidiabetic Drugs Market Share by Application (2012-2017)
Figure India Oral Antidiabetic Drugs Sales and Growth Rate (2012-2017)
Figure India Oral Antidiabetic Drugs Revenue and Growth Rate (2012-2017)
Figure India Oral Antidiabetic Drugs Sales Price Trend (2012-2017)
Table India Oral Antidiabetic Drugs Sales by Manufacturers (2012-2017)
Table India Oral Antidiabetic Drugs Market Share by Manufacturers (2012-2017)
Table India Oral Antidiabetic Drugs Sales by Type (2012-2017)
Table India Oral Antidiabetic Drugs Market Share by Type (2012-2017)
Table India Oral Antidiabetic Drugs Sales by Application (2012-2017)
Table India Oral Antidiabetic Drugs Market Share by Application (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Oral Antidiabetic Drugs Global Market Share (2012-2017)
Table Abbott Basic Information List
Table Abbott Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Oral Antidiabetic Drugs Global Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Oral Antidiabetic Drugs Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Oral Antidiabetic Drugs Global Market Share (2012-2017)
Table Sunpharma Basic Information List
Table Sunpharma Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sunpharma Oral Antidiabetic Drugs Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Oral Antidiabetic Drugs Global Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Oral Antidiabetic Drugs Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Oral Antidiabetic Drugs Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Oral Antidiabetic Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Antidiabetic Drugs
Figure Manufacturing Process Analysis of Oral Antidiabetic Drugs
Figure Oral Antidiabetic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Oral Antidiabetic Drugs Major Manufacturers in 2015
Table Major Buyers of Oral Antidiabetic Drugs
Table Distributors/Traders List
Figure Global Oral Antidiabetic Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Oral Antidiabetic Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Oral Antidiabetic Drugs Sales Forecast by Regions (2017-2022)
Table Global Oral Antidiabetic Drugs Sales Forecast by Type (2017-2022)
Table Global Oral Antidiabetic Drugs Sales Forecast by Application (2017-2022)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の経口抗糖尿病薬市場:販売動向2017(Global Oral Antidiabetic Drugs Sales Market Report 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆